Disintegration and esophageal irritation profiles of alendronate formulations: implications for clinical safety and efficacy.

Background: Fosamax (alendronate sodium, Merck & Co., Inc., Whitehouse Station, NJ, USA) is an effective oral bisphosphonate widely used to treat and prevent osteoporosis, with a safety and tolerability profile similar to placebo in clinical trials. It has been evaluated in clinical trials with over...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Applied Research Vol. 5; no. 2; pp. 253 - 266
Autores principales:	Epstein S, Geusens P, Fisher JE, Hill SL, Roy S, Rodan G, Muniappa N, Wollenberg GK, Handt L, Kelly N, Chan C, Reszka AA, Prahalada S
Formato:	pictorial research tables/charts Journal Article
Publicado:	Therapeutic Solutions LLC 2005
Acceso en línea:	Ver este registro en EBSCOhost